Molina Healthcare, Inc $MOH Shares Bought by Royce & Associates LP

Royce & Associates LP boosted its stake in shares of Molina Healthcare, Inc (NYSE:MOH) by 36.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 52,521 shares of the company’s stock after purchasing an additional 13,910 shares during the quarter. Royce & Associates LP’s holdings in Molina Healthcare were worth $9,114,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Torren Management LLC purchased a new stake in Molina Healthcare in the 4th quarter worth approximately $26,000. Miller Global Investments LLC purchased a new position in Molina Healthcare in the 4th quarter valued at about $27,000. Cromwell Holdings LLC raised its stake in Molina Healthcare by 211.9% in the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after purchasing an additional 125 shares during the last quarter. Rakuten Securities Inc. raised its stake in Molina Healthcare by 5,020.0% in the 4th quarter. Rakuten Securities Inc. now owns 256 shares of the company’s stock valued at $44,000 after purchasing an additional 251 shares during the last quarter. Finally, MUFG Securities EMEA plc purchased a new position in Molina Healthcare in the 2nd quarter worth approximately $48,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Truist Financial raised their target price on shares of Molina Healthcare from $180.00 to $205.00 and gave the stock a “hold” rating in a research note on Monday, May 11th. Barclays raised their target price on shares of Molina Healthcare from $161.00 to $199.00 and gave the stock an “underweight” rating in a research note on Tuesday. UBS Group raised their target price on shares of Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a research note on Friday, May 22nd. Bank of America raised shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price on the stock in a research note on Wednesday, April 29th. Finally, Sanford C. Bernstein reissued an “outperform” rating on shares of Molina Healthcare in a research note on Friday, March 13th. Three analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and a consensus target price of $178.53.

Molina Healthcare Stock Down 0.1%

MOH stock opened at $177.62 on Friday. The firm has a market cap of $9.25 billion, a PE ratio of 52.55 and a beta of 0.85. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. The firm’s 50 day moving average price is $163.27 and its 200-day moving average price is $160.70. Molina Healthcare, Inc has a one year low of $121.06 and a one year high of $311.52.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. The business had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company’s revenue was down 3.1% compared to the same quarter last year. During the same period in the prior year, the business posted $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, equities research analysts anticipate that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Insider Buying and Selling

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares in the company, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. The SEC filing for this sale provides additional information. 1.44% of the stock is owned by insiders.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.